Genome Editing Technologies Market Report 2024-2034 - Emerging Economies Projected to Boost Industry Growth
27 juin 2024 07h20 HE
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Genome Editing Technologies Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Genome Editing...
STALICLA publishes pioneering phase 1b data on precision treatment for autism spectrum disorder in Biomedicines
27 juin 2024 07h10 HE
|
STALICLA
Press Release STALICLA’s precision psychiatry study highlights strong EEG-based target engagement of STP1 treatment in defined subgroup of patients with autism and numerical improvement in core...
Proscia And Nucleai Partner To Broaden Access To AI Predictive Biomarkers
25 juin 2024 08h00 HE
|
Proscia
PHILADELPHIA and CHICAGO, June 25, 2024 (GLOBE NEWSWIRE) -- Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, has partnered with Nucleai, a leading spatial AI...
Global Tissue Diagnostics Market Size To Worth USD 10.8 Billion By 2033 | CAGR of 8.22%
24 juin 2024 20h00 HE
|
SPHERICAL INSIGHTS LLP
New York, United States , June 24, 2024 (GLOBE NEWSWIRE) -- The Global Tissue Diagnostics Market Size is to Grow from USD 4.9 Billion in 2023 to USD 10.8 Billion by 2033, at a Compound Annual Growth...
Global Biomarker Clinical Phase Outsourcing Services Market Size To Exceed USD 46.5 Billion By 2033 l CAGR of 20.02%
20 juin 2024 22h00 HE
|
SPHERICAL INSIGHTS LLP
New York, United States , June 20, 2024 (GLOBE NEWSWIRE) -- The Global Biomarker Clinical Phase Outsourcing Services Market Size is to Grow from USD 7.5 Billion in 2023 to USD 46.5 Billion by 2033,...
Companion Diagnostics Market Anticipated To Grow At 12.5% CAGR, Reaching USD 26.0 Billion By 2033 | Dimension Market Research
10 juin 2024 10h24 HE
|
Dimension Market Research
New York, June 10, 2024 (GLOBE NEWSWIRE) -- Market Overview The Global Companion Diagnostics Market size is expected to reach USD 9.0 billion by 2024 and is further anticipated to reach USD...
Cyclacel’s Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting
04 juin 2024 08h00 HE
|
Cyclacel
- Novel CDK2/9 inhibitor fadraciclib induces anaphase catastrophe, a novel cancer-specific mechanism of action - BERKELEY HEIGHTS, N.J., June 04, 2024 (GLOBE NEWSWIRE) --...
At ASCO 2024, Treos Bio Reports Key Survival Results for Chemo-Free Regimen of PolyPEPI1018 Peptide Immunotherapy and Roche’s PD-L1 Inhibitor in Late-Stage Colorectal Cancer
03 juin 2024 07h00 HE
|
Treos Bio Corp.
Treos Bio reports promising survival results for chemo-free PolyPEPI1018 cancer vaccine combined with Roche's PD-L1 inhibitor in MSS mCRC at 2024 ASCO
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Across Multiple Cancers and the Ability to Quantify ER Pathway Activation in Breast Cancer from a Simple Blood Test
02 juin 2024 10h00 HE
|
Precede Biosciences, Inc.
HER2 status was accurately assessed in 172 patients with advanced breast, gastroesophageal, and ovarian cancersER status was accurately assessed and the level of ER pathway activation quantified in 87...
Asia-Pacific Genomic Cancer Panel and Profiling Market Research 2023-2024 & 2033: Advancements in Genomic Research and Increasing Focus on Precision Medicine Within Oncology
30 mai 2024 06h39 HE
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Genomic Cancer Panel and Profiling Market: Focus on Application, End User, and Country - Analysis and Forecast, 2023-2033" report has been...